IR情報

2023/10/17~2024/03/14

IR情報&株価推移

日付始値高値安値終値前日比出来高時価総額25日乖離
2024
03/141,8401,8641,8401,864+1.14%26,300229億9871万+1.19%
03/131,8431,8641,8351,843+0.38%25,600227億3960万-0.27%
03/121,8271,8361,7951,836+0.71%44,400226億5323万-1.13%
03/111,8181,8291,8061,8230%55,800224億9283万-2.2%
03/081,8221,8341,8111,823-0.33%32,700224億9283万-2.62%
03/071,8411,8461,8141,829-0.05%43,800225億6686万-2.76%
03/061,8211,8451,8201,830-0.11%46,500225億7920万-3.12%
03/051,8151,8541,8121,832+0.77%39,900226億388万-3.53%
03/041,8321,8431,8181,818-0.66%40,800224億3114万-4.72%
03/011,8661,8671,8241,830-1.93%65,000225億7920万-4.59%
02/291,8601,8751,8501,866+0.38%26,600230億2338万-3.17%
02/281,8561,8801,8561,859+0.27%31,800229億3702万-3.88%
02/271,8411,8561,8361,854+1.09%26,800228億7532万-4.58%
02/261,8201,8421,8091,834+0.22%42,200226億2856万-5.9%
02/221,8371,8381,8161,8300%29,700225億7920万-6.39%
02/211,8401,8401,8141,830-0.27%31,100225億7920万-6.78%
02/201,8251,8531,8231,835+0.66%50,600226億4089万-6.95%
02/191,8281,8341,8161,823-0.16%48,700224億9283万-7.93%
02/161,7801,8361,7801,826+2.82%80,100225億2985万-8.1%
02/151,8031,8051,7721,776-1.88%123,500219億1293万-10.98%
02/141,8101,8191,7971,810-0.82%69,600223億3244万-9.68%
02/131,8401,8401,8021,825-0.92%114,800225億1751万-9.34%
02/091,8451,8831,8371,842-0.16%118,200227億2726万-8.9%
02/081,8351,8951,8341,845-10.31%469,500227億6428万-9.07%
02/0715:30 印ルピンとのバイオシミラーの共同開発の進捗に関するお知らせ
02/0715:30 2024年3月期第3四半期決算短信〔日本基準〕(連結)
02/072,0502,0782,0362,057+1.18%99,700253億8001万+1.03%
02/062,0402,0502,0272,033-1.17%27,600250億8389万-0.05%
02/052,0162,0642,0112,057+2.03%54,800253億8001万+1.18%
02/022,0222,0292,0112,016-0.25%37,400248億7414万-0.69%
02/012,0402,0402,0172,021-1.03%23,900249億3583万-0.35%
01/312,0282,0452,0222,042+0.34%22,900251億9494万+0.79%
01/302,0832,0832,0352,035-2.3%59,300251億857万+0.59%
01/292,0732,0872,0622,083+1.31%30,300257億81万+3.07%
01/262,0612,0872,0522,056-0.29%51,900253億6767万+2.03%
01/252,0602,0692,0452,0620%30,000254億4170万+2.69%
01/242,0492,0652,0412,062+0.68%40,000254億4170万+3%
01/232,0632,0682,0422,048-0.73%31,600252億6897万+2.66%
01/222,0322,0632,0182,063+2.79%54,900254億5404万+3.77%
01/192,0032,0392,0032,007+0.2%33,500247億6309万+1.31%
01/182,0002,0261,9982,003-0.6%43,700247億1374万+1.26%
01/172,0732,0742,0152,015-2.52%49,200248億6180万+1.97%
01/162,0432,0752,0262,067+1.87%79,700255億340万+4.71%
01/152,0102,0291,9922,029+1.25%61,700250億3454万+2.94%
01/122,0082,0141,9962,004-0.3%50,200247億2608万+1.78%
01/112,0322,0372,0012,010-0.2%47,000248億11万+2.03%
01/102,0282,0452,0132,014-0.69%61,900248億4946万+2.29%
01/092,0452,0722,0272,028-0.59%50,900250億2220万+3%
01/052,0362,0542,0272,040+0.54%62,100251億7026万+3.61%
01/041,9732,0351,9712,029+1%35,600250億3454万+3.2%
2023
12/292,0102,0151,9922,009-0.35%25,100247億8777万+2.4%
12/282,0292,0292,0012,016-0.1%65,700248億7414万+2.86%
12/271,9982,0271,9422,018+1.82%111,100248億9882万+3.17%
12/261,9622,0071,9621,982+0.92%41,200244億5463万+1.48%
12/251,9711,9901,9621,964-0.51%30,800242億3254万+0.67%
12/221,9581,9821,9481,974+0.97%38,700243億5593万+1.28%
12/211,9581,9761,9421,955-1.06%51,300241億2150万+0.31%
12/201,9481,9961,9481,976+2.22%64,200243億8060万+1.39%
12/1912:00 当社子会社による英国Roslin Technologies LimitedとのiPS細胞作製技術に関するライセンス契約締結のお知らせ
12/191,8841,9331,8831,933+2.28%61,300238億5005万-0.72%
12/181,8811,8901,8611,890-1.1%63,100233億1950万-2.98%
12/151,9001,9201,8921,911+1.59%56,100235億7861万-2.15%
12/141,9061,9221,8771,881-0.53%48,900232億846万-3.88%
12/131,8841,8981,8671,891+0.37%47,300233億3184万-3.52%
12/121,9261,9291,8791,884-1.77%68,800232億4547万-3.98%
12/111,9471,9531,9141,918-1.84%77,000236億6498万-1.99%
12/081,9611,9751,9421,954-0.76%49,000241億916万+0.21%
12/0712:30 2024年3月期(第27期)第2四半期決算説明資料
12/071,9822,0011,9671,969-1.45%34,400242億9424万+1.49%
12/061,9892,0031,9831,998+0.71%29,100246億5205万+3.52%
12/051,9952,0291,9841,984-1.34%43,800244億7931万+3.44%
12/041,9912,0251,9912,011+1.06%37,400248億1245万+5.45%
12/012,0312,0311,9861,990-2.02%71,400245億5334万+5.07%
11/302,0122,0432,0122,031+0.45%68,200250億5921万+7.92%
11/2910:00 NTTコミュニケーションズ株式会社との協業に関するお知らせ
11/291,9632,0401,9632,022+2.9%282,600249億4817万+8.3%
11/281,9361,9651,9331,965+1.5%50,500242億4488万+6.1%
11/271,9421,9531,9261,936+0.05%26,700238億8707万+5.22%
11/241,9381,9621,9351,935+0.21%38,500238億7473万+5.74%
11/221,9521,9551,9301,931-0.57%75,200238億2538万+6.04%
11/211,9191,9491,9141,942+1.04%45,000239億6110万+7.17%
11/201,9281,9451,9201,922-0.31%51,800237億1433万+6.6%
11/171,9501,9871,9141,928-1.63%85,800237億8836万+7.29%
11/161,9571,9691,9411,960+0.15%53,100241億8319万+9.38%
11/151,9701,9701,9251,957+0.93%104,300241億4618万+9.64%
11/141,9721,9721,9361,939-1.22%51,300239億2408万+8.99%
11/132,0032,0031,9491,963-2%74,800242億2021万+10.78%
11/102,0042,0111,9632,003-0.55%97,900247億1374万+13.48%
11/091,9512,0151,9502,014+2.49%220,800248億4946万+14.76%
11/081,9381,9711,9181,965+1.34%184,400242億4488万+12.41%
11/071,8171,9481,8161,939+11.63%527,000239億2408万+11.24%
11/0615:30 剰余金の配当(中間配当)および期末配当予想の修正(増配)に関するお知らせ
11/0615:30 2024年3月期第2四半期決算短信〔日本基準〕(連結)
11/061,7601,7711,7291,737-0.74%81,800214億3174万-0.23%
11/021,7351,7541,7221,750+1.86%68,200215億9213万+0.11%
11/011,7341,7461,7151,718+0.17%35,700211億9731万-2.11%
10/311,6891,7231,6861,715+1.24%51,000211億6029万-2.67%
10/301,7031,7121,6761,694-1.4%107,700209億119万-4.24%
10/271,6881,7191,6861,718+2.51%41,300211億9731万-3.27%
10/261,6741,6881,6701,676-0.48%30,300206億7909万-5.95%
10/251,6771,6951,6711,684+0.66%28,400207億7780万-5.97%
10/241,6481,6761,6021,673+2.14%59,800206億4208万-7.06%
10/231,6481,6581,6291,638-1.44%68,500202億1024万-9.45%
10/201,6631,6731,6351,662-0.89%60,800205億636万-8.68%
10/191,6991,7051,6771,677-2.39%51,900206億9143万-8.41%
10/181,7121,7181,6801,718+1.24%75,100211億9731万-6.63%
10/171,7241,7421,6931,697-1.79%123,400209億3820万-8.12%
10/169:05 COVID-19ワクチン「IRO-203」開発の進捗報告